Price$42.03-20.40 (-32.68%)
2026-03-052026-06-08
News · 26 weeks76-86%
2025-12-142026-06-07
Mix3290d
- Insider15(47%)
- SEC Filings7(22%)
- Other5(16%)
- Analyst3(9%)
- Earnings2(6%)
Latest news
25 items- SECSEC Form SD filed by Inspire Medical Systems Inc.SD - Inspire Medical Systems, Inc. (0001609550) (Filer)
- ANALYSTInspire Medical Systems downgraded by BofA Securities with a new price targetBofA Securities downgraded Inspire Medical Systems from Neutral to Underperform and set a new price target of $39.00
- INSIDEROfficer Rondoni John sold $114,302 worth of shares (2,641 units at $43.28), decreasing direct ownership by 9% to 27,165 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDEROfficer Rondoni John sold $30,107 worth of shares (700 units at $43.01), decreasing direct ownership by 2% to 29,806 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Inspire Medical Systems Inc.SCHEDULE 13G/A - Inspire Medical Systems, Inc. (0001609550) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Inspire Medical Systems Inc.SCHEDULE 13G/A - Inspire Medical Systems, Inc. (0001609550) (Subject)
- INSIDERDirector Mccormick Shawn sold $31,536 worth of shares (696 units at $45.31) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 27,712 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- SECSEC Form 144 filed by Inspire Medical Systems Inc.144 - Inspire Medical Systems, Inc. (0001609550) (Subject)
- SECSEC Form S-8 filed by Inspire Medical Systems Inc.S-8 - Inspire Medical Systems, Inc. (0001609550) (Filer)
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- ANALYSTInspire Medical Systems downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Inspire Medical Systems from Overweight to Neutral and set a new price target of $55.00
- ANALYSTInspire Medical Systems downgraded by BofA Securities with a new price targetBofA Securities downgraded Inspire Medical Systems from Buy to Neutral and set a new price target of $53.00
- INSIDERDirector Ellis Gary Lee was granted 3,562 shares, increasing direct ownership by 49% to 10,838 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Mead Dana G Jr. was granted 3,562 shares, increasing direct ownership by 16% to 26,213 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Tansey Casey M was granted 3,562 shares, increasing direct ownership by 16% to 26,286 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Curet Myriam was granted 3,562 shares, increasing direct ownership by 106% to 6,927 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Burks Cynthia was granted 3,562 shares, increasing direct ownership by 134% to 6,213 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Broader Shelley G was granted 3,562 shares, increasing direct ownership by 73% to 8,471 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Mccormick Shawn was granted 3,562 shares, increasing direct ownership by 14% to 28,408 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Melenikiotou Georgia was granted 3,562 shares and covered exercise/tax liability with 50 shares, increasing direct ownership by 79% to 7,985 units (SEC Form 4) (for withholding tax)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- SECSEC Form 10-Q filed by Inspire Medical Systems Inc.10-Q - Inspire Medical Systems, Inc. (0001609550) (Filer)
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- PRInspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 GuidanceFirst quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2026. "Our first quarter results reflect revenue growth and improved adjusted operating income and cash flow," said Tim Herbert, Chairman and CEO of Inspire Medical Systems. "We remain focused on t
- PRInspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare ConferenceMINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026. Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website at https://investors.i
- INSIDERSEC Form 4 filed by Broader Shelley G4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
INSP FAQ
7 questionsWhat does Inspire Medical Systems Inc. do?
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is...Where does INSP stock trade?
Inspire Medical Systems Inc. (INSP) is listed on NYSE.What sector and industry is INSP in?
Inspire Medical Systems Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Inspire Medical Systems Inc. go public?
Inspire Medical Systems Inc. (INSP) completed its IPO in 2018.What are analysts saying about INSP?
Inspire Medical Systems Inc. has had 8 recent analyst actions on file. The most recent action was from BofA Securities: Underperform with a $3900.00 price target on 2026-05-22. Recent price targets cluster around $3900.00.What companies are similar to INSP?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare INSP side-by-side with any of them on Quantisnow.How can I track INSP on Quantisnow?
Quantisnow aggregates Inspire Medical Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow INSP to receive live email and push alerts on every new disclosure.